PharmaCyte Biotech, Inc. SEC filings PMCB
PharmaCyte Biotech, Inc. has 472 filings in SEC EDGAR's recent list, going back to Aug 20, 2001. Its latest annual report, Form 10-K, was filed on Jul 29, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 14, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (auditor change). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Mar 9, 2026 | Mar 30, 2026 |
| PRE 14A | Preliminary proxy statement | Feb 27, 2026 | Mar 30, 2026 |
| DEF 14A | Proxy statement | Oct 6, 2025 | Oct 30, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 24, 2025 | Oct 30, 2025 |
| DEFA14A | Additional proxy material | Mar 10, 2025 | — |
| DEF 14A | Proxy statement | Mar 10, 2025 | Apr 24, 2025 |
| DEF 14A | Proxy statement | Mar 27, 2024 | Apr 29, 2024 |
| DEF 14A | Proxy statement | Jul 31, 2023 | Aug 31, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 19, 2023 | Aug 31, 2023 |
| DEF 14A | Proxy statement | Jun 5, 2023 | Jun 5, 2023 |
| PRE 14A | Preliminary proxy statement | May 25, 2023 | Jul 7, 2023 |
| DEF 14A | Proxy statement | Nov 25, 2022 | Dec 28, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 15, 2022 | Dec 28, 2022 |
| DEFA14A | Additional proxy material | Aug 16, 2022 | — |
| DEFA14A | Additional proxy material | Jul 28, 2022 | — |
| DEFA14A | Additional proxy material | Jul 21, 2022 | — |
| DEFA14A | Additional proxy material | Jul 19, 2022 | — |
| DEFA14A | Additional proxy material | Jul 11, 2022 | — |
| DEFA14A | Additional proxy material | Jun 15, 2022 | — |
Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PMCB (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1157075
- Former names
- NUVILEX, INC. (until Jan 9, 2015); EFOODSAFETY COM INC (until Mar 17, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.